Haloperidol lactate
- Level
- Commodity
- Parent
- 51332500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51332520This classification denotes a dopamine antagonist with the molecular formula C21H23ClFNO2.C3H6O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6387S86PK3, chemically known as 1-butanone, 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)- but more generally known as haloperidol lactate, which bears US NIH Compound Identifier 3559. European Medicines Agency schedules Haloperidol lactate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02453MIG. Most nations, for tariff and trade purposes, schedule haloperidol lactate under HS 29333999 and SITC 51574. As of Q4 2014, HALOPERIDOL LACTATE remains US FDA's Preferred Term for this commodity. Haloperidol lactate bears US NLM identifiers UMLS ID C0720809 and NCI Concept Code C78110. SMILES: CC(C(=O)O)O.C1CC(CCC1C(=O)CCCN2CCC(CC2)(C3CCC(CC3)CL)O)F.
Same parent
Under 51332500 · 27Activities that produce or sell this
KBLI · 8Inherited from family 51330000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.